Discussion on:

The amazing race for the cheapest and fastest DNA machine

Nice roundup on the sequencing industry. If you look at the software companies that are aggressively pursuing the space, I think you will find the same dynamic. The industry is finding out what we are "best at". As with the computer industry, as the equipments become more powerful and cheaper, the value added increasingly is enabled by the software.

Tandem, massively-parallel processing - definitely is changing the world, and will continue to do so. Good article. -- Jeff

I have no idea why all the fuss about the three. Can anyone
elaborate? Intel has the chips and HD, Google has the search engine
so does MSN and Yahoo. Sony is very well know for the best TV
Trinitarian 3 gun HDTV or camera. All are meant for the work they
are made. I do not mind Toshiba, Samsung the upcoming TV or cell
phone, and that is a beauty, Sanyo, Panasonic or any more. I have no
idea why we are fighting for the choice when now we can afford only
one TV in the room, 1 cell in the hand or use only one, search from
one source at one time. Now I see we have the notebook with the 3D
and Polaroid spectacles. That is the too according Click on line
BBC. has the problem. Two newly launched 3D laptops - the Asus G51
J3D and the Acer Aspire 5738DG - are tested out by Marc Cieslak.
Pictures are set to revolutionise online searches, with the results
becoming more personal than ever.
http://news.bbc.co.uk/2/hi/programmes/click_online/default.stm I
thank you Firozali A.Mulla DBA

It's still a probablity process of filling in the blanks using possible arrangements but much information is ommitted and unkown since it is misunderstood or not yet investigated. The liability requirements will be a hinderance toward having legitimacy for any insurance or medical applications. I'd recommend a long-term study that includes genetic profiles of thousands of people that indicates the determination of phenotypes and other attributes along with disease risks. Then determine the effectiveness of the suggested genotypic expression by comparing with what arises during their lives with the traits of their children, health, and aging. I'm sure variability will be inherent so how will quality assurance be possible? In that regard, don't consider anything for insurance or medical purposes. The idyllic statement about using this being useful for general treatment is just that, another dubious utopian wish, especially since the standard of treatment in the USA is so variable anyway no matter if it is provided by a general practitioner or specialist.

donnydo77, you areright on the money. Truly accurate, rapid and CHEAP, repeat CHEAP sequencing will lead to ever-larger databases of information for comparative and research purposes. I have a "vision" of what the ideal sequencer looks and acts like, what it's specifications are, and how it would be invaluable to the health care industry on behalf of patients.